6 results on '"Codini M"'
Search Results
2. Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells.
- Author
-
Cataldi S, Arcuri C, Hunot S, Légeron FP, Mecca C, Garcia-Gil M, Lazzarini A, Codini M, Beccari T, Tasegian A, Fioretti B, Traina G, Ambesi-Impiombato FS, Curcio F, and Albi E
- Subjects
- Animals, Calcitriol pharmacology, Cell Line, Disease Models, Animal, Hippocampus drug effects, Hippocampus pathology, Inflammation Mediators metabolism, MPTP Poisoning enzymology, Male, Mice, Mice, Inbred C57BL, Nitric Oxide Synthase Type II metabolism, Parkinson Disease, Secondary pathology, Sphingomyelins metabolism, Hippocampus enzymology, Parkinson Disease, Secondary chemically induced, Parkinson Disease, Secondary enzymology, Sphingomyelin Phosphodiesterase metabolism
- Abstract
Neutral sphingomyelinase is known to be implicated in growth arrest, differentiation, proliferation, and apoptosis. Although previous studies have reported the involvement of neutral sphingomyelinase in hippocampus physiopathology, its behavior in the hippocampus during Parkinson's disease remains undetected. In this study, we show an upregulation of inducible nitric oxide synthase and a downregulation of neutral sphingomyelinase in the hippocampus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- (MPTP-) induced mouse model of Parkinson's disease. Moreover, the stimulation of neutral sphingomyelinase activity with vitamin 1,25-dihydroxyvitamin D3 reduces specifically saturated fatty acid sphingomyelin by making sphingomyelin a less rigid molecule that might influence neurite plasticity. The possible biological relevance of the increase of neutral sphingomyelinase in Parkinson's disease is discussed.
- Published
- 2017
- Full Text
- View/download PDF
3. Mouse Thyroid Gland Changes in Aging: Implication of Galectin-3 and Sphingomyelinase.
- Author
-
Traina G, Cataldi S, Siccu P, Loreti E, Ferri I, Sidoni A, Codini M, Gizzi C, Sichetti M, Ambesi-Impiombato FS, Beccari T, Curcio F, and Albi E
- Subjects
- Animals, Galectin 3 analysis, Male, Mice, Receptors, Thyrotropin analysis, Sphingomyelin Phosphodiesterase analysis, Thyrotropin analysis, Aging pathology, Galectin 3 physiology, Sphingomyelin Phosphodiesterase physiology, Thyroid Gland pathology
- Abstract
Prevalence of thyroid dysfunction and its impact on cognition in older people has been demonstrated, but many points remain unclarified. In order to study the effect of aging on the thyroid gland, we compared the thyroid gland of very old mice with that of younger ones. We have first investigated the changes of thyroid microstructure and the possibility that molecules involved in thyroid function might be associated with structural changes. Results from this study indicate changes in the height of the thyrocytes and in the amplitude of interfollicular spaces, anomalous expression/localization of thyrotropin, thyrotropin receptor, and thyroglobulin aging. Thyrotropin and thyrotropin receptor are upregulated and are distributed inside the colloid while thyroglobulin fills the interfollicular spaces. In an approach aimed at defining the behavior of molecules that change in different physiopathological conditions of thyroid, such as galectin-3 and sphingomyelinase, we then wondered what was their behavior in the thyroid gland in aging. Importantly, in comparison with the thyroid of young animals, we have found a higher expression of galectin-3 and a delocalization of neutral sphingomyelinase in the thyroid of old animals. A possible relationship between galectin-3, neutral sphingomyelinase, and aging has been discussed.
- Published
- 2017
- Full Text
- View/download PDF
4. Hypovitaminosis D3, Leukopenia, and Human Serotonin Transporter Polymorphism in Anorexia Nervosa and Bulimia Nervosa.
- Author
-
Tasegian A, Curcio F, Dalla Ragione L, Rossetti F, Cataldi S, Codini M, Ambesi-Impiombato FS, Beccari T, and Albi E
- Subjects
- Adolescent, Adult, Aged, Female, Genotype, Humans, Middle Aged, PPAR gamma metabolism, Receptors, Calcitriol metabolism, Young Adult, Anorexia Nervosa blood, Anorexia Nervosa genetics, Bulimia Nervosa blood, Bulimia Nervosa genetics, Cholecalciferol blood, Leukopenia blood, Leukopenia genetics, Serotonin Plasma Membrane Transport Proteins genetics
- Abstract
Vitamin D3 has been described to have different extraskeletal roles by acting as parahormone in obesity, diabetes, cancer, cognitive impairment, and dementia and to have important regulatory functions in innate immunity. There are no studies showing extraskeletal changes associated with hypovitaminosis D3 in eating disorders. Methods. We have analyzed the blood of 18 patients affected by anorexia nervosa and bulimia nervosa collected over a 15-month period. We performed a panel of chemical and clinical analyses: the assay of vitamin D3, the immunoblotting of vitamin D receptor and peroxisome proliferator-activated receptor gamma, and the genotyping of 5-hydroxytryptamine transporter linked polymorphic region. Results. We choose 18 patients with a normal blood test profile such as thyroid hormones, hepatic and renal parameters, triglycerides, proteins, vitamin B12, and folic acid. Among these emerged the case of a woman with long-term anorexia nervosa and the case of a woman with long-term bulimia nervosa both complicated by anxiety and depression, severe hypovitaminosis D3, decrease of vitamin D receptor, leukopenia, and 5-hydroxytryptamine transporter linked polymorphic region short allele. Conclusion. The results induce hypothesising that the severe hypovitaminosis D3 might be responsible for the lack of the inflammatory response and the depressive symptoms in patients with long-term eating disorders.
- Published
- 2016
- Full Text
- View/download PDF
5. In Vitro Protective Effects of Lycium barbarum Berries Cultivated in Umbria (Italy) on Human Hepatocellular Carcinoma Cells.
- Author
-
Ceccarini MR, Vannini S, Cataldi S, Moretti M, Villarini M, Fioretti B, Albi E, Beccari T, and Codini M
- Subjects
- Antineoplastic Agents administration & dosage, Apoptosis drug effects, Cell Proliferation drug effects, Cell Survival drug effects, Cytoprotection drug effects, Hep G2 Cells, Humans, Italy, Treatment Outcome, Carcinoma, Hepatocellular prevention & control, Fruit chemistry, Liver Neoplasms prevention & control, Lycium chemistry, Phytotherapy methods, Plant Extracts administration & dosage
- Abstract
Lycium barbarum is a famous plant in the traditional Chinese medicine. The plant is known to have health-promoting bioactive components. The properties of Lycium barbarum berries cultivated in Umbria (Italy) and their effect on human hepatocellular carcinoma cells (HepG2) have been investigated in this work. The obtained results demonstrated that the Lycium barbarum berries from Umbria region display high antioxidant properties evaluated by total phenolic content and ORAC method, on hydrophilic and lipophilic fractions. Moreover, on HepG2 cell line Lycium barbarum berries extract did not change cell viability analyzed by MTT and Trypan blue exclusion assay and did not induce genotoxic effect analyzed by comet assay. Furthermore, it was demonstrated, for the first time, that the berries extract showed a protective effect on DNA damage, expressed as antigenotoxic activity in vitro . Finally, Lycium barbarum berries extract was able to modulate the expression of genes involved in oxidative stress, proliferation, apoptosis, and cancer. In particular, downexpression of genes involved in tumor migration and invasion (CCL5), in increased risk of metastasis and antiapoptotic signal (DUSP1), and in carcinogenesis (GPx-3 and PTGS1), together with overexpression of tumor suppressor gene (MT3), suggested that Umbrian Lycium barbarum berries could play a protective role against hepatocellular carcinoma., Competing Interests: The authors declare that there are no competing interests regarding the publication of this paper and the mentioned received funding in Acknowledgments.
- Published
- 2016
- Full Text
- View/download PDF
6. e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease.
- Author
-
Cataldi S, Codini M, Hunot S, Légeron FP, Ferri I, Siccu P, Sidoni A, Ambesi-Impiombato FS, Beccari T, Curcio F, and Albi E
- Subjects
- Animals, Interleukin-6 metabolism, Male, Mice, Inbred C57BL, Tyrosine 3-Monooxygenase metabolism, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pharmacology, Cadherins metabolism, Parkinson Disease etiology, Parkinson Disease metabolism
- Abstract
Today a large number of studies are focused on clarifying the complexity and diversity of the pathogenetic mechanisms inducing Parkinson disease. We used 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin that induces Parkinson disease, to evaluate the change of midbrain structure and the behavior of the anti-inflammatory factor e-cadherin, interleukin-6, tyrosine hydroxylase, phosphatase and tensin homolog, and caveolin-1. The results showed a strong expression of e-cadherin, variation of length and thickness of the heavy neurofilaments, increase of interleukin-6, and reduction of tyrosine hydroxylase known to be expression of dopamine cell loss, reduction of phosphatase and tensin homolog described to impair responses to dopamine, and reduction of caveolin-1 known to be expression of epithelial-mesenchymal transition and fibrosis. The possibility that the overexpression of the e-cadherin might be implicated in the anti-inflammatory reaction to MPTP treatment by influencing the behavior of the other analyzed molecules is discussed.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.